ID

15138

Description

TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC; ODM derived from: https://clinicaltrials.gov/show/NCT02065362

Lien

https://clinicaltrials.gov/show/NCT02065362

Mots-clés

Versions (1)
  1. 18/05/2016 18/05/2016 -
Téléchargé le

18 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

Anglais

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must meet the following eligibility inclusion criteria at the time of procurement:
Description

Time Procurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1709695
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
Description

Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory

Type de données

boolean

Alias
UMLS CUI [1]
C0278952
UMLS CUI [2,1]
C2931822
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C2347678
ebv positive tumor
Description

Malignant Neoplasms Epstein-Barr virus test positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1611703
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
the patient must meet the following eligibility criteria to be included for treatment:
Description

Inclusion criteria Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0087111
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
Description

Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory

Type de données

boolean

Alias
UMLS CUI [1]
C0278952
UMLS CUI [2,1]
C2931822
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C2347678
ebv positive tumor
Description

Malignant Neoplasms Epstein-Barr virus test positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1611703
patients with life expectancy greater than or equal to 6 weeks
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
bilirubin less than or equal to 3x upper limit of normal
Description

Bilirubin, total measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201913
ast less than or equal to 5x upper limit of normal
Description

Aspartate aminotransferase measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201899
hgb > 8.0g/dl (can be transfused)
Description

Hemoglobin | Transfusion (procedure)

Type de données

boolean

Alias
UMLS CUI [1]
C0019046
UMLS CUI [2]
C1879316
creatinine less than or equal to 2x upper limit of normal for age
Description

Creatinine measurement, serum | Upper Limit of Normal Age

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2,1]
C1519815
UMLS CUI [2,2]
C0001779
pulse oximetry of > 90% on room air
Description

Pulse Oximetry on room air

Type de données

boolean

Alias
UMLS CUI [1,1]
C0034108
UMLS CUI [1,2]
C2709070
off investigational therapy for 4 weeks prior to study entry
Description

Off Investigational Therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1518543
UMLS CUI [1,2]
C0949266
karnofsky or lansky score of greater than or equal to 50%
Description

Karnofsky Performance Status | Lansky Play-Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1522275
sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after the study is concluded. the male partner should use a condom.
Description

Patients Sexually active | Contraceptive methods | Condoms, Male

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0241028
UMLS CUI [2]
C0700589
UMLS CUI [3]
C0009653
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
at time of procurement:
Description

Time Procurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C1709695
•known hiv positivity
Description

HIV Seropositivity

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
at time of treatment:
Description

Time Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0087111
pregnant or lactating
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
severe intercurrent infection
Description

Intercurrent infection Severe

Type de données

boolean

Alias
UMLS CUI [1,1]
C0240021
UMLS CUI [1,2]
C0205082
Retour au début de la page

Similar models

Eligibility EBV-positive Nasopharyngeal Carcinoma NCT02065362

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Time Procurement
Item
the patient must meet the following eligibility inclusion criteria at the time of procurement:
boolean
C0040223 (UMLS CUI [1,1])
C1709695 (UMLS CUI [1,2])
Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory
Item
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
boolean
C0278952 (UMLS CUI [1])
C2931822 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C2347678 (UMLS CUI [2,3])
Malignant Neoplasms Epstein-Barr virus test positive
Item
ebv positive tumor
boolean
C0006826 (UMLS CUI [1,1])
C1611703 (UMLS CUI [1,2])
Informed Consent
Item
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent
boolean
C0021430 (UMLS CUI [1])
Inclusion criteria Therapeutic procedure
Item
the patient must meet the following eligibility criteria to be included for treatment:
boolean
C1512693 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Nasopharyngeal cancer recurrent | Nasopharyngeal carcinoma Disease Primary Refractory
Item
nasopharyngeal carcinoma in first or subsequent relapse or with primary refractory disease
boolean
C0278952 (UMLS CUI [1])
C2931822 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C2347678 (UMLS CUI [2,3])
Malignant Neoplasms Epstein-Barr virus test positive
Item
ebv positive tumor
boolean
C0006826 (UMLS CUI [1,1])
C1611703 (UMLS CUI [1,2])
Life Expectancy
Item
patients with life expectancy greater than or equal to 6 weeks
boolean
C0023671 (UMLS CUI [1])
Bilirubin, total measurement
Item
bilirubin less than or equal to 3x upper limit of normal
boolean
C0201913 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
ast less than or equal to 5x upper limit of normal
boolean
C0201899 (UMLS CUI [1])
Hemoglobin | Transfusion (procedure)
Item
hgb > 8.0g/dl (can be transfused)
boolean
C0019046 (UMLS CUI [1])
C1879316 (UMLS CUI [2])
Creatinine measurement, serum | Upper Limit of Normal Age
Item
creatinine less than or equal to 2x upper limit of normal for age
boolean
C0201976 (UMLS CUI [1])
C1519815 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])
Pulse Oximetry on room air
Item
pulse oximetry of > 90% on room air
boolean
C0034108 (UMLS CUI [1,1])
C2709070 (UMLS CUI [1,2])
Off Investigational Therapy
Item
off investigational therapy for 4 weeks prior to study entry
boolean
C1518543 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Karnofsky Performance Status | Lansky Play-Performance Status
Item
karnofsky or lansky score of greater than or equal to 50%
boolean
C0206065 (UMLS CUI [1])
C1522275 (UMLS CUI [2])
Patients Sexually active | Contraceptive methods | Condoms, Male
Item
sexually active patients must be willing to utilize one of the more effective birth control methods during the study and for 6 months after the study is concluded. the male partner should use a condom.
boolean
C0030705 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2])
C0009653 (UMLS CUI [3])
Informed Consent
Item
informed consent explained to, understood by and signed by patient/guardian. patient/guardian given copy of informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Time Procurement
Item
at time of procurement:
boolean
C0040223 (UMLS CUI [1,1])
C1709695 (UMLS CUI [1,2])
HIV Seropositivity
Item
•known hiv positivity
boolean
C0019699 (UMLS CUI [1])
Time Therapeutic procedure
Item
at time of treatment:
boolean
C0040223 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Intercurrent infection Severe
Item
severe intercurrent infection
boolean
C0240021 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial